SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Omega-3

BASF wants a share of pharma omega-3 market

By Gareth Macdonald , 15-Oct-2012
Last updated on 15-Oct-2012 at 10:47 GMT2012-10-15T10:47:32Z

BASF wants a share of pharma omega-3 market

BASF wants a share of the $1.5bn global market for drug grade omega-3 and expects the plant it is building to start shipping product early next year. 

The German chemicals giant acquired Equateq – now called BASF Pharma Callanish – in May, describing the Scotland-based firm as the global leader in the production of concentrated omega-3 fatty acids and citing its EPA and DHA products as key drivers for the deal.

in-Pharmatechnologist.com spoke with BASF spokesman Ralf Fink at CPhI in Madrid, Spain Iast week to ask how the firm views the current market and how it intends to grow this new part of its business.

“First of all the market is growing nicely and there is enough space for all of us. Today we see two major players in the market and the dominant player is Pronova…they created the market by having a technology in place to supply firms like GSK.”

To this end – Fink continued – BASF chose CPhI to showcase its own omega-3 active pharmaceutical ingredient (API), which it will produce at the new plant it is building in Callanish on the Isle of Lewis in Scotland.

The technology they are using is simulated moving bed technology…which is a patent protected, unique, cost efficient and very flexible manufacturing technology,” Fink said, adding that the plant’s ability to produce a variety of different omega-3 grades is key to meeting customers’ demands.

He declined to specify how much omega-3 BASF will be able to produce at the new plant – other than that it will be a substantial amount – but did say that: “It is a world class manufacturing facility…that we plan to have up and running and supplying product to our customers very early next year.” 

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars